Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
07 2023
Historique:
received: 05 02 2023
revised: 13 05 2023
accepted: 17 05 2023
medline: 7 7 2023
pubmed: 26 5 2023
entrez: 25 5 2023
Statut: ppublish

Résumé

On September 7 and 8, 2022, Healthy Environment and Endocrine Disruptors Strategies, an Environmental Health Sciences program, convened a scientific workshop of relevant stakeholders involved in obesity, toxicology, or obesogen research to review the state of the science regarding the role of obesogenic chemicals that might be contributing to the obesity pandemic. The workshop's objectives were to examine the evidence supporting the hypothesis that obesogens contribute to the etiology of human obesity; to discuss opportunities for improved understanding, acceptance, and dissemination of obesogens as contributors to the obesity pandemic; and to consider the need for future research and potential mitigation strategies. This report details the discussions, key areas of agreement, and future opportunities to prevent obesity. The attendees agreed that environmental obesogens are real, significant, and a contributor at some degree to weight gain at the individual level and to the global obesity and metabolic disease pandemic at a societal level; moreover, it is at least, in theory, remediable.

Identifiants

pubmed: 37230178
pii: S0002-9165(23)63923-1
doi: 10.1016/j.ajcnut.2023.05.024
pii:
doi:

Substances chimiques

Endocrine Disruptors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-337

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES030283
Pays : United States

Informations de copyright

Copyright © 2023 American Society for Nutrition. All rights reserved.

Auteurs

Jerrold J Heindel (JJ)

Healthy Environment and Endocrine Disruptor Strategies, Boseman, Montana, United States. Electronic address: jerryheindel@gmail.com.

Jessica A Alvarez (JA)

Department of Medicine, Emory University, Atlanta, GA, United States.

Ella Atlas (E)

Health Canada, Ottawa, Ontario, Canada.

Matthew C Cave (MC)

Department of Medicine, Pharmacology and Toxicology, Biochemistry and Molecular Genetics, University of Louisville, Lousiville, KY, United States.

Vaia Lida Chatzi (VL)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

David Collier (D)

Department of Pediatrics, East Carolina University, Greenville, NC, United States.

Barbara Corkey (B)

Chobanian and Avedesian School of Medicine, Boston University, Boston, MA, United States.

Douglas Fischer (D)

Environmental Health Sciences, Boseman, MT, United States.

Michael I Goran (MI)

Department of Pediatrics, Keck School of Medicine, USC, Los Angeles, CA, United States.

Sarah Howard (S)

Healthy Environment and Endocrine Disruptor Strategies, Boseman, Montana, United States.

Scott Kahan (S)

National Center for Weight and Wellness, Johns Hopkins Blumberg School of Public Health, Baltimore, MD, United States.

Matthias Kayhoe (M)

Environmental Health Sciences, Boseman, MT, United States.

Suneil Koliwad (S)

Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Catherine M Kotz (CM)

Department of Integrative Biology and Physiology, University of Minnesota and Minneapolis VA Health Care System, Minneapolis, MN, United States.

Michele La Merrill (M)

Department of Environmental Toxicology, University of California, Davis, CA, United States.

Tim Lobstein (T)

World Obesity Federation, London, United Kingdom.

Carey Lumeng (C)

Department of Pediatrics, University of Michigan Medical School, University of Michigan, Ann Arbor, MI, United States.

David S Ludwig (DS)

New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, MA, United States.

Robert H Lustig (RH)

Department of Physiology, Miguel Hernandez University of Elche, Elche, Spain.

Pete Myers (P)

Environmental Health Sciences, Boseman, MT, United States.

Angel Nadal (A)

Department of Physiology, Miguel Hernandez University of Elche, Elche, Spain.

Leonardo Trasande (L)

Department of Pediatrics, New York University Langone Health, New York, NY, United States; Department of Population Health, New York University Langone Health, New York, NY, United States.

Leanne M Redman (LM)

Department of Reproductive Endocrinology & Women's Health, Pennington Biomedical Research Center, Baton Rouge, LA, United States.

Matthew S Rodeheffer (MS)

Department of Comparative Medicine, Yale University, New Haven, CT, United States.

Robert M Sargis (RM)

Department of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, United States.

Jacqueline M Stephens (JM)

Department of Pediatrics, New York University Langone Health, New York, NY, United States.

Thomas R Ziegler (TR)

Department of Medicine, Emory University, Atlanta, GA, United States.

Bruce Blumberg (B)

Department of Developmental and Cell BiologyUniversity of California Irvine, Irvine, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH